Statistical significance goes before the Supreme Court

The Economist View blog posts a letter from economist Steve Ziliak (link) describing a case due to be argued before the Supreme Court next week on whether “drug manufacturers and other companies [should] be required to report the adverse effect of a product on users, if the effect is not statistically significantly different from zero at the 5% level.” Briefs presented before the court commenting on the case are here (link). The blog post also links to this page, as well as to some of Ziliak’s writing on significance testing.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.